Claravis is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Isotretinoin.
Product ID | 0555-1056_10276cf5-9f65-4a32-8b0d-201fa5b2bc20 |
NDC | 0555-1056 |
Product Type | Human Prescription Drug |
Proprietary Name | Claravis |
Generic Name | Isotretinoin |
Dosage Form | Capsule, Liquid Filled |
Route of Administration | ORAL |
Marketing Start Date | 2006-05-18 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA076135 |
Labeler Name | Teva Pharmaceuticals USA, Inc. |
Substance Name | ISOTRETINOIN |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | Retinoid [EPC],Retinoids [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2006-05-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA076135 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-08-05 |
Marketing Category | ANDA |
Application Number | ANDA076135 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-05-18 |
Ingredient | Strength |
---|---|
ISOTRETINOIN | 30 mg/1 |
SPL SET ID: | a31fd109-d0fd-4ab9-ba98-a3d64333c18d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0555-1054 | Claravis | Isotretinoin |
0555-1055 | Claravis | Isotretinoin |
0555-1056 | Claravis | Isotretinoin |
0555-1057 | Claravis | Isotretinoin |
0378-6611 | Amnesteem | isotretinoin |
0378-6612 | Amnesteem | isotretinoin |
0378-6614 | Amnesteem | isotretinoin |
0245-0570 | Isotretinoin | Isotretinoin |
0245-0571 | Isotretinoin | Isotretinoin |
0245-0573 | Isotretinoin | Isotretinoin |
0245-0575 | Isotretinoin | Isotretinoin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CLARAVIS 97432561 not registered Live/Pending |
BARR Laboratories, Inc. 2022-05-27 |
CLARAVIS 76503621 not registered Dead/Abandoned |
Barr Laboratories, Inc. 2003-04-03 |